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thod. ArAbstract Simple, rapid and accurate new vierordt’s (VI) method or simultaneous equation (SE)
method is developed and validated for the simultaneous estimation of dutasteride (DU) and tam-
sulosin hydrochloride (TA) in pure and pharmaceutical dosage form. The method is based on
the measurement of absorbance at two wavelengths 240.6 nm and 279.4 nm, kmax of DU and TA
in methanol respectively. Calibration curves are linear in the concentration ranges 20–40 lg/ml
for DU and 16–32 lg/ml for TA. LOD, LOQ, precision and recovery studies are calculated. The
proposed method is successfully applied for simultaneous estimation of DU and TA in pure and
pharmaceutical dosage form.
ª 2013 Production and hosting by Elsevier B.V. on behalf of King Saud University.1. Introduction
Dutasteride is a 4 – azasteroid compound, chemically it is
5a,17b-N-{2,5 bis(triﬂuoromethyl)phenyl}-3-oxo-4-azaand-
rost-1-ene-17-carboxamide (Scheme 1). It is a selective inhibi-
tor of both the type 1 and type 2 isoforms of steroid 5
alpha-reductase, an intracellular enzyme that converts testos-
terone to dihydrotestosterone. It is used in the treatment of91 9443988722; fax: +91
m (T. Sivakkumar).
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2002; Marberger, 2006).
Tamsulosin HCl is a selective antagonist at alpha-1A and
alpha-1B-adrenoceptors in the prostate, prostatic capsule,
prostatic urethra, and bladder neck. Blockage of these
receptors causes relaxation of smooth muscles in the bladder
neck and prostate, and thus decreases urinary outﬂow
resistance in men. It is chemically (-)-(R)-5-[2-[[2-(O-Ethoxy-
phenoxy)ethyl]amino]propyl]-2-methoxybenzenesulfonamide
monohydrochloride (Scheme 2), (Budavari, 2001; Sweetman,
2002; Ichioka et al., 2004).
Detailed literature survey was carried out and revealed that
very few analytical methods have been reported for the estima-
tion of DU and TA individually and in combination with other
drugs like UV (Choudhari et al., 2012; Pande et al., 2009;
Kamila et al., 2010), HPTLC (Dipti B. Patel et al., 2011; Bari
et al., 2011), RP-HPLC (Dipti B. Patel et al., 2010), LC–MS/
MS (Agarval et al., 2008; Rahkonen et al., 2007) and chiraling Saud University.
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Figure 1 Overlain spectra of DU and TA. (a) UV spectrum of
DU; (b) UV spectrum of TA.
Scheme 1 Structure of Dutasteride.
Scheme 2 Structure of Tamsulosin HCl.
2 P. Giriraj, T. Sivakkumarseparations (Maier et al., 2005). However the SE method was
not reported for the estimation of these drugs in combined
dosage form.
1.1. Objective
The objective of the present study was to develop a simple, pre-
cise, accurate and rapid SE method for the estimation of DU
and TA in pharmaceutical dosage form.
2. Experimental
2.1. Apparatus
Shimadzu 1650 UV–Vis double beam spectrophotometer with
uv probe software and 1 cm matched quartz cells were used.
2.2. Materials and reagents
Pharmaceutical grade of dutasteride and tamsulosin HCl was
kindly supplied by AN therapeutics, (Pondicherry, India), ana-
lytical grade methanol (S.D ﬁne chemical Ltd., Mumbai, In-
dia) was used throughout these experiments. The commercial
tablets used containing 0.5 mg DU and 0.4 mg TA per tablet
were manufactured by cipla Pvt Ltd., (Mumbai, India).
2.3. Standard solutions
Stock solutions of DU and TA were prepared by dissolving in
methanol 10 mg of DU and TA separately in a 100 ml volu-
metric ﬂask, sonicated for 5 min. Final volumes of both the
solutions were adjusted with methanol to get stock solutions
with the concentration of 100 lg/ml of DU and TA.
2.4. Procedure
25 lg/ml solutions of DU and TA drugs were prepared from
stock solutions and scanned individually in the range of 200–Please cite this article in press as: Giriraj, P., Sivakkumar, T. Simultaneo
dosage form by vierordt’s method. Arabian Journal of Chemistry (2013400 nm (Fig. 1) and the kmax values were found to be
240.6 nm for DU (k1) and 279.4 nm for TA (k2) (Jefferey
et al., 1989; Beckett et al., 1997).
The concentrations of drugs in sample solutions were deter-
mined by the SE method using the following formula.
Cx ¼ A2ay1  A1ay2=ax2ay1  ax1ay2
Cy ¼ A1ax2  A2ax1=ax2ay1  ax1ay2
Where Cx and Cy are the concentration of DU and TA, ax1
and ax2 are absorptivities of DU at 240.6 nm and 279.4 nm,
ay1 and ay2 are absorptivities of TA at 240.6 nm and
279.4 nm, respectively.
2.5. Determination of absorptivity value
The absorptivity of each solution was calculated by using the
following formula (Khan et al., 2010):
Absorptivity ¼ Absorbance=concðgm=100 mlÞ
The developed method was validated as per ICH (ICH
Q2(R1), 2005) guidelines.
3. Results
3.1. Speciﬁcity
Speciﬁcity was studied by measuring the absorbance of DU
and TA individually at 240.6 nm and 279.4 nm against the
blank and comparing the absorbance of drug solutions to
the blank. No interference was observed.us estimation of dutasteride and tamsulosin hydrochloride in tablet
), http://dx.doi.org/10.1016/j.arabjc.2013.07.013
Figure 2 Calibration graph for DU.
Figure 3 Calibration graph for TA.
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The absorbances were measured for DU and TA in the con-
centration range of 20, 25, 30, 35, 40 lg/ml and 16, 20, 24,
28, 32 lg/ml at 240.06 nm and 279.4 nm for both the drugs
respectively. Calibration graphs were plotted for DU at
240.6 nm and TA at 279.4 nm. (Figs. 2 and 3 respectively)
Absorptivity values were calculated for each concentration
and presented (Tables 1 and 2).
3.3. Accuracy
Recovery studies were carried out by measuring the absor-
bance of added standard solution of both DU and TA in
50%, 100% and 150% levels to the preanalysed sample solu-
tions at 240.6 and 279.4 nm. The amount of DU and TA
was calculated and results are presented in Table 3.
3.4. Precision
Inter and intraday precision studies were done by repeated
measurements of the absorbance of standard mixed solution
in triplicate in same day and single time for three days respec-Please cite this article in press as: Giriraj, P., Sivakkumar, T. Simultaneo
dosage form by vierordt’s method. Arabian Journal of Chemistry (2013tively by the proposed assay method without changing the
method procedure. Percentage RSD was calculated and results
are presented in Table 4.
3.5. Ruggedness
A study was conducted to determine the effect of variation in
analyst to analyst, lab to lab and instrument to instrument in
triplicatemeasurement as per the assaymethod.%RSDwas cal-
culated for each condition and results are presented in Table 5.
3.6. Robustness
Robustness study was carried out by changing the wavelength
in ±1 nm from 240.6 nm to 279.4 nm and the results are pre-
sented in Table 6.
3.7. Stability
Stability of drug solutions was determined by keeping the drug
solution for nine days at room temperature and the absor-
bance of sample solution in each day was measured. Results
are presented in Table 7.us estimation of dutasteride and tamsulosin hydrochloride in tablet
), http://dx.doi.org/10.1016/j.arabjc.2013.07.013
Table 2 Absorptivity value for TA.
Concentration (lg/ml) Absorbance Absorptivity Absorbance Absorptivity
k1–240.60 k1–240.60 k2–279.40 k2–279.40
16 0.045 28.12 0.177 110.6
20 0.056 28.00 0.221 110.5
24 0.067 27.91 0.267 111.2
28 0.079 28.21 0.321 114.6
32 0.09 28.12 0.356 111.2
Absorptivity for k1 28.07 Absorptivity for k2 111.6
Table 3 Recovery results for DU and TA.
Concentration (%) Added amount (mg) Amount recovered (mg) Amount recovered (%)
DU/TA DU TA DU TA DU TA
50 0.750 0.600 0.740 0.609 98.69 101.61
100 1.500 1.200 1.192 1.497 99.84 99.38
150 2.250 1.8 1.785 2.244 99.74 99.19
Table 1 Absorptivity value for DU.
Concentration (lg/ml) Absorbance Absorptivity Absorbance Absorptivity
k1–240.60 k1–240.60 k2–279.40 k2–279.40
20 0.414 207 0.112 56
25 0.517 206.8 0.140 56
30 0.622 207.3 0.168 56
35 0.724 206.8 0.196 56
40 0.837 209.2 0.224 56
Absorptivity for k1 207.4 Absorptivity for k2 56
Table 5 Ruggedness results for DU and TA.
Parameters DU TA
Amount present (mg) Amount present (%) RSD% Amount present (mg) Amount present (%) RSD%
Analyst I 0.4990 99.80 0.0028 0.4027 100.67 0.0098
II 0.5002 100.04 0.0047 0.4016 100.39 0.0129
Instrument I 0.5015 100.30 0.0026 0.3979 99.49 0.0135
II 0.4955 99.10 0.0047 0.4027 100.61 0.0193
Table 4 Intra day and inter day precision results.
Parameters Sampling time DU TA
Amount present (mg) Amount present (%) RSD% Amount present (mg) Amount present (%) RSD%
Intra day precision 0 h 0.5019 100.38 0.0041 0.3980 99.500 0.0060
8th h 0.4997 99.950 0.0067 0.4010 100.27 0.0074
16th h 0.5013 100.26 0.0035 0.4005 100.14 0.0074
Inter day precision Ist day 0.5037 100.75 0.0018 0.4013 100.33 0.0058
2nd day 0.5015 100.29 0.0025 0.4005 100.18 0.0081
3rd day 0.4950 99.01 0.0057 0.4029 100.73 0.0145
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Table 6 Results observed by changing the wavelength ± nm.
Wavelength (nm) DU Wavelength (nm) TA
Amount present (mg) Amount present (%) RSD% Amount present (mg) Amount present (%) RSD%
239.6 0.4948 98.97 0.0059 278.4 0.3953 98.82 0.0033
241.6 0.4922 98.44 0.0039 280.4 0.3926 98.155 0.0024
Table 7 Stability data for DU and TA.
Day DU TA
Amount present (mg) Amount present (%) Amount present (mg) Amount present (%)
1 0.5004 100.08 0.4084 102.12
2 0.5032 100.64 0.4055 101.39
3 0.4934 98.68 0.4000 100.00
4 0.4964 99.29 0.3955 98.87
5 0.4981 99.50 0.3946 98.66
6 0.4975 999.50 0.3934 98.36
6 0.4979 99.58 0.3902 97.56
7 0.4940 99.89 0.3910 97.75
8 0.4940 98.80 0.3892 97.36
9 0.4916 98.33 0.3889 97.23
Simultaneous estimation of dutasteride and tamsulosin hydrochloride in tablet dosage form by vierordt’s method 53.8. Apply the developed and validated method to the marketed
dosage form
20 Urimax-D Tablets were accurately weighed and powdered
and the powder weight equivalent to 1.5 mg of DU and
1.2 mg of TA was transferred to a 50 ml volumetric ﬂask sep-
arately and sufﬁcient methanol was added to dissolve it. Then
the solutions were sonicated for 15 min. Then ﬁnal volume was
adjusted with methanol and ﬁltered by vacuum ﬁltration. The
ﬁltrate was centrifuged at 10,000 RPM for 30 min. Then clear
supernatant solutions were transferred to a separate ﬂask with-
out disturbing the sediment. Then absorbance was measured at
240.6 nm and 279.4 nm for minimum six times. Amount of
DU and TA in each tablet was calculated and results are pre-
sented in Table 8.
4. Discussion
The SE method was developed and validated for the simulta-
neous estimation of DU and TA in pure and tablet dosage
forms.Table 8 Assay results of tablet dosage forms.
DU
Amount present (mg) Amount present (% label claim)
0.512468 102.4937
0.508616 101.7232
0.512523 102.5045
0.510556 102.1111
0.509062 101.8124
0.506676 101.3353
0.509984 101.9967
SD 0.421158
% RSD 0.004129
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ear in the concentration range from 20–40 lg/ml to 16–32 lg/
ml. Regression coefﬁcient and slope were calculated from the
calibration graph 0.999 and 0.021 for DU and 0.996 and
0.011 TA respectively. Intraday and interday precision was
performed by replicate measurement of absorbance of mixed
standard solutions and percentage RSD was found to be
0.0047%, 0.0033% for DU and 0.0086%, 0.0093% for TA.
The recovery studies were carried out to ensure the reproduc-
ibility and reliability of this method by adding a known
amount of standard drug to the preanalysed sample in three
different levels (50%, 100% and 150%). The percentage recov-
eries of the three concentrations were found to be close to
100%, indicative of high accuracy. The Limit of Detection
and Limit of Quantiﬁcation were theoretically calculated for
DU and TA which were found to be 0.1111 lg/ml,
0.2683 lg/ml and 0.336 lg/ml and 0.8131 lg/ml, respectively.
Robustness and Ruggedness were also carried out and percent-
age RSD was found to be less than 0.5%. Stability of DU and
TA in methanol was found to be stable up to 9 days at room
temperature.TA
Amount present (mg) Amount present (% label claim)
0.390497 97.62428
0.401403 100.3507
0.402444 100.611
0.398937 99.73417
0.404173 101.0433
0.403869 100.9672
0.40022 100.0551
SD 1.281944
% RSD 0.012812
us estimation of dutasteride and tamsulosin hydrochloride in tablet
), http://dx.doi.org/10.1016/j.arabjc.2013.07.013
6 P. Giriraj, T. SivakkumarThe developed simple, rapid, sensitive, accurate and eco-
nomical SE or vierordt’s method for the routine quantitative
determination of DU and TA in tablet dosage form, will re-
duce unnecessary tedious sample preparations and the cost
of reagents without any interferences and prior separations.Acknowledgement
Authors are thankful to the UGC-BSR, New Delhi, India, for
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